ImageneBio (IMA) Shares Outstanding (2020 - 2025)

ImageneBio has reported Shares Outstanding (Entity) for 6 years, with the latest figure at $11.2 million in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 178.06% year-over-year to $11.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.2 million (up 178.06% YoY) and the FY2025 annual result came in at $11.2 million, up 178.06% from the prior year.
• Shares Outstanding (Entity) grew to $11.2 million in Q4 2025 per IMA's latest filing, from $8.5 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $11.2 million in Q4 2025 and troughed at $320842.0 in Q1 2021.
• A 5-year average of $3.9 million and a median of $3.6 million in 2023 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2021 and 2024: Shares Outstanding (Entity) jumped 1249.4% in 2021, then changed 0.0% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $2.3 million in 2021, then climbed by 29.57% to $3.0 million in 2022, then soared by 33.1% to $4.0 million in 2023, then changed by 0.0% to $4.0 million in 2024, then surged by 178.06% to $11.2 million in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $11.2 million, $8.5 million, and $4.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.